Brigitte Nedelec

Brigitte Nedelec

Auto-generated profile, based on publicly available information

Brigitte Nedelec

Institut National de la Santé et de la Recherche Médicale, Unité mixte de Recherche U_1163, Institut IMAGINE, Université Paris Descartes, Sorbonne Paris Cité, Paris, France

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 1997 in Nature Genetics
Verified
Journal Article
Closed access
TCThe French FMF Consortium
The French FMF Consortium
ABAlain Bernot
Alain Bernot
CCChristian Clepet
Christian Clepet
CDCorinne Dasilva
Corinne Dasilva
CDCatherine Devaud
Catherine Devaud
GGGilles Grateau
Gilles Grateau

1 July 1999 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
CCCécile Cazeneuve
Cécile Cazeneuve
TSTamara Sarkisian
Tamara Sarkisian
CPChristophe Pêcheux
Christophe Pêcheux
MDMichel Dervichian
Michel Dervichian
BNBrigitte Nédelec
Brigitte Nédelec
SASerge Amselem
Serge Amselem

1 August 1998 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
ABA Bernot
A Bernot
CSC Da Silva
C Da Silva
JPJ L Petit
J L Petit
CCC Cruaud
C Cruaud
CCC Caloustian
C Caloustian
ITI Touitou
I Touitou
Familial Mediterranean fever (FMF) is an autosomal recessive disorder characterized by recurring attacks of fever and serositis. It affects primarily North African Jews, Armenians, Turks and Arabs, in which a founder effect has been demonstrated. The marenostrin-pyrinencoding gene has been proposed as a candidate gene for the disease (MEFV), on the basis of the identification of putative mutations clustered in exon 10 (M680V, M694I, M694V and V726A), each segregating with one ancestral haplotype. In a search for additional MEFV mutations in 120 apparently non-founder FMF chromosomes, we observed eight novel mutations in exon 2 (E148Q, E167D and T267I), exon 5 (F479L) and exon 10 (I692del K695R, A744S and R761H). Except for E148Q and K695R, all mutations were found in a single chromosome. Mutation E148Q was found in all ethnic groups studied and in association with a novel ancestral haplotype in non-Ashkenazi Jews (S2). Altogether, these new findings definitively establish the marenos-trin/pyrin-encoding gene as the MEFV locus.

14 June 2012 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
SVSophie Valleix
Sophie Valleix
JGJulian D. Gillmore
Julian D. Gillmore
FBFrank Bridoux
Frank Bridoux
PMPalma P. Mangione
Palma P. Mangione
ADAhmet Dogan
Ahmet Dogan
VBVittorio Bellotti
Vittorio Bellotti
We describe a kindred with slowly progressive gastrointestinal symptoms and autonomic neuropathy caused by autosomal dominant, hereditary systemic amyloidosis. The amyloid consists of Asp76Asn variant β2-microglobulin. Unlike patients with dialysis-related amyloidosis caused by sustained high plasma concentrations of wild-type β2-microglobulin, the affected members of this kindred had normal renal function and normal circulating β2-microglobulin values. The Asp76Asn β2-microglobulin variant was thermodynamically unstable and remarkably fibrillogenic in vitro under physiological conditions. Previous studies of β2-microglobulin aggregation have not shown such amyloidogenicity for single-residue substitutions. Comprehensive biophysical characterization of the β2-microglobulin variant, including its 1.40-Å, three-dimensional structure, should allow further elucidation of fibrillogenesis and protein misfolding.

1 August 2006 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SVSophie Valleix
Sophie Valleix
FNFlorence Niel
Florence Niel
BNBrigitte Nedelec
Brigitte Nedelec
MAMarie-Paule Algros
Marie-Paule Algros
CSClaire Schwartz
Claire Schwartz
BKBernadette Kantelip
Bernadette Kantelip

21 January 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
SVSophie Valleix
Sophie Valleix
GVGuglielmo Verona
Guglielmo Verona
NJNoemie Jourde-Chiche
Noemie Jourde-Chiche
BNBrigitte Nédelec
Brigitte Nédelec
PMP. Patrizia Mangione
P. Patrizia Mangione
VBVittorio Bellotti
Vittorio Bellotti
Apolipoprotein C-III deficiency provides cardiovascular protection, but apolipoprotein C-III is not known to be associated with human amyloidosis. Here we report a form of amyloidosis characterized by renal insufficiency caused by a new apolipoprotein C-III variant, D25V. Despite their uremic state, the D25V-carriers exhibit low triglyceride (TG) and apolipoprotein C-III levels, and low very-low-density lipoprotein (VLDL)/high high-density lipoprotein (HDL) profile. Amyloid fibrils comprise the D25V-variant only, showing that wild-type apolipoprotein C-III does not contribute to amyloid deposition in vivo. The mutation profoundly impacts helical structure stability of D25V-variant, which is remarkably fibrillogenic under physiological conditions in vitro producing typical amyloid fibrils in its lipid-free form. D25V apolipoprotein C-III is a new human amyloidogenic protein and the first conferring cardioprotection even in the unfavourable context of renal failure, extending the evidence for an important cardiovascular protective role of apolipoprotein C-III deficiency. Thus, fibrate therapy, which reduces hepatic APOC3 transcription, may delay amyloid deposition in affected patients.